Indian Equity Market has shown an aggressive growth even after the economy was beaten down by the pandemic. The Indian equity market has soared from its lows of March 2020, edging to beat the UK equity market in terms of market value and cut the chas

The IT giant great recorded a phenomenal recorded a strong performance in India but faltered overseas. While Indian market grew by 14.1 QoQ, it declined by 2 in Continental Europe. While the dollar revenue grew 15.5 YoY and 4 QoQ on CC basis the

Equitas Small Finance banks ranks the best amongst its peers in the Small Finance Business space with a diversified asset mix and a largely secured portfolio. It is the first bank to waive off NMC charges in January’21 and offered no minimum deposi

The country-wide coal shortage from the power industry has served as a boon for Solar Industries India. Looking at the current scenario, the sudden increase in coal demand and power generation, the company anticipates a stronger future outlook, beyon

Macro Environment overview of FY22 so far - With layoffs and salary cuts, majority of the households have felt the pressure so much so that their spends on the daily essentials dramatically reduced. No new household have been formed with a deceler

The multi-sector conglomerate gets the final approval for the demerger of the company into two segments Pharma and Financial services. The demerger will birth two new entities namely, Piramal Enterprises Limited (PEL) and Piramal Pharma Limited (PPL)

With Covid restrictions easing and economic revival, the paint industry is gaining steady demand for paints from project business sector. This is concluded from the conversations held with various paint dealer hailing from UP According to the deal

After a rather grim start of the year with only Rs. 1.7bn worth sales booking in Q1FY22, Oberoi Realty (Market Cap: Rs. 341bn) reported a stellar Q2FY22 performance with sales bookings worth Rs. 8.3bn across 200 units with no new launches in the quar

Sri Lanka seems to be beaten down by the recurring Covid-19 waves. Even before it could recover from the third wave, it found itself fighting with infectious fourth wave. The mortality remained high with its positivity rate close to 15, however, the

With the economic recovery coming into play, there is a sense of mixed feelings looming over. Increased activities showed the recovery tracker rising from 103 to 105, and the PMI long-term average rising up to 53.7 from 53.5. This change came from

The retail giant, DMart’s bullish momentum spills into Q2 and there seems to be no looking back. This is proved with the stock price zooming 94 in one year and outperforming the Nifty50 benchmark which only grew 54 in the same period. The reta

Merck, also widely known as MSD, and its partner Ridgeback Biotherapeutics reported robust results for Molnupiravir Phase 3 trials from the interim analysis. The drug is said to reduce the risk of hospitalization or death by 50 in patients suffering